Global Cell and Gene Therapy CDMO Services Market Research Report 2024, Forecast to 2032

October 2024 | 171 pages | ID: GC438A17C122EN
Bosson Research

Abstracts

Report Overview

Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) services involve companies providing specialized expertise and infrastructure for the development, manufacturing, and commercialization of cell and gene therapy products on behalf of biopharmaceutical companies. These services encompass a range of activities, including process development, analytical testing, regulatory support, and manufacturing at various scales, from preclinical to commercial production. CDMOs play a critical role in accelerating the translation of cell and gene therapies from research to clinical application by offering tailored solutions to meet the unique requirements of each therapy, ultimately helping to bring innovative treatments to patients more efficiently and effectively.

The global Cell and Gene Therapy CDMO Services market size was estimated at USD 5598 million in 2023 and is projected to reach USD 72403.19 million by 2032, exhibiting a CAGR of 32.90% during the forecast period.

North America Cell and Gene Therapy CDMO Services market size was estimated at USD 2397.37 million in 2023, at a CAGR of 28.20% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Cell and Gene Therapy CDMO Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy CDMO Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy CDMO Services market in any manner.

Global Cell and Gene Therapy CDMO Services Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Catalent

Lonza

Thermo Fisher

WuXi AppTec

Charles River

OxfordBioMedica

BrammerBio

CELLfor CURE

OBiO Technology

GenScript

Esco

Nikon

FUJIFILM

Pharmaron

Porton

Medicilon

JOINN Laboratories

Sofpromed

eXmoor

OmniaBio

RoslinCT

BioCentriq

PolTREG

Miltenyi Bioindustry

Market Segmentation (by Type)

Autologous Cell Therapy Products

Allogeneic Cell Therapy Products

Market Segmentation (by Application)

SMBs

Large Companies

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cell and Gene Therapy CDMO Services Market
• Overview of the regional outlook of the Cell and Gene Therapy CDMO Services Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy CDMO Services Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Cell and Gene Therapy CDMO Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Cell and Gene Therapy CDMO Services
1.2 Key Market Segments
  1.2.1 Cell and Gene Therapy CDMO Services Segment by Type
  1.2.2 Cell and Gene Therapy CDMO Services Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CELL AND GENE THERAPY CDMO SERVICES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Cell and Gene Therapy CDMO Services Market Size (M USD) Estimates and Forecasts (2019-2032)
  2.1.2 Global Cell and Gene Therapy CDMO Services Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CELL AND GENE THERAPY CDMO SERVICES MARKET COMPETITIVE LANDSCAPE

3.1 Global Cell and Gene Therapy CDMO Services Sales by Manufacturers (2019-2024)
3.2 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell and Gene Therapy CDMO Services Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell and Gene Therapy CDMO Services Sales Sites, Area Served, Product Type
3.6 Cell and Gene Therapy CDMO Services Market Competitive Situation and Trends
  3.6.1 Cell and Gene Therapy CDMO Services Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Cell and Gene Therapy CDMO Services Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 CELL AND GENE THERAPY CDMO SERVICES INDUSTRY CHAIN ANALYSIS

4.1 Cell and Gene Therapy CDMO Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY CDMO SERVICES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 CELL AND GENE THERAPY CDMO SERVICES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy CDMO Services Sales Market Share by Type (2019-2024)
6.3 Global Cell and Gene Therapy CDMO Services Market Size Market Share by Type (2019-2024)
6.4 Global Cell and Gene Therapy CDMO Services Price by Type (2019-2024)

7 CELL AND GENE THERAPY CDMO SERVICES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy CDMO Services Market Sales by Application (2019-2024)
7.3 Global Cell and Gene Therapy CDMO Services Market Size (M USD) by Application (2019-2024)
7.4 Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2019-2024)

8 CELL AND GENE THERAPY CDMO SERVICES MARKET CONSUMPTION BY REGION

8.1 Global Cell and Gene Therapy CDMO Services Sales by Region
  8.1.1 Global Cell and Gene Therapy CDMO Services Sales by Region
  8.1.2 Global Cell and Gene Therapy CDMO Services Sales Market Share by Region
8.2 North America
  8.2.1 North America Cell and Gene Therapy CDMO Services Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Cell and Gene Therapy CDMO Services Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Cell and Gene Therapy CDMO Services Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Cell and Gene Therapy CDMO Services Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Cell and Gene Therapy CDMO Services Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 CELL AND GENE THERAPY CDMO SERVICES MARKET PRODUCTION BY REGION

9.1 Global Production of Cell and Gene Therapy CDMO Services by Region (2019-2024)
9.2 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2019-2024)
9.3 Global Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Cell and Gene Therapy CDMO Services Production
  9.4.1 North America Cell and Gene Therapy CDMO Services Production Growth Rate (2019-2024)
  9.4.2 North America Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Cell and Gene Therapy CDMO Services Production
  9.5.1 Europe Cell and Gene Therapy CDMO Services Production Growth Rate (2019-2024)
  9.5.2 Europe Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Cell and Gene Therapy CDMO Services Production (2019-2024)
  9.6.1 Japan Cell and Gene Therapy CDMO Services Production Growth Rate (2019-2024)
  9.6.2 Japan Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Cell and Gene Therapy CDMO Services Production (2019-2024)
  9.7.1 China Cell and Gene Therapy CDMO Services Production Growth Rate (2019-2024)
  9.7.2 China Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2019-2024)

10 KEY COMPANIES PROFILE

10.1 Catalent
  10.1.1 Catalent Cell and Gene Therapy CDMO Services Basic Information
  10.1.2 Catalent Cell and Gene Therapy CDMO Services Product Overview
  10.1.3 Catalent Cell and Gene Therapy CDMO Services Product Market Performance
  10.1.4 Catalent Business Overview
  10.1.5 Catalent Cell and Gene Therapy CDMO Services SWOT Analysis
  10.1.6 Catalent Recent Developments
10.2 Lonza
  10.2.1 Lonza Cell and Gene Therapy CDMO Services Basic Information
  10.2.2 Lonza Cell and Gene Therapy CDMO Services Product Overview
  10.2.3 Lonza Cell and Gene Therapy CDMO Services Product Market Performance
  10.2.4 Lonza Business Overview
  10.2.5 Lonza Cell and Gene Therapy CDMO Services SWOT Analysis
  10.2.6 Lonza Recent Developments
10.3 Thermo Fisher
  10.3.1 Thermo Fisher Cell and Gene Therapy CDMO Services Basic Information
  10.3.2 Thermo Fisher Cell and Gene Therapy CDMO Services Product Overview
  10.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Product Market Performance
  10.3.4 Thermo Fisher Cell and Gene Therapy CDMO Services SWOT Analysis
  10.3.5 Thermo Fisher Business Overview
  10.3.6 Thermo Fisher Recent Developments
10.4 WuXi AppTec
  10.4.1 WuXi AppTec Cell and Gene Therapy CDMO Services Basic Information
  10.4.2 WuXi AppTec Cell and Gene Therapy CDMO Services Product Overview
  10.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Product Market Performance
  10.4.4 WuXi AppTec Business Overview
  10.4.5 WuXi AppTec Recent Developments
10.5 Charles River
  10.5.1 Charles River Cell and Gene Therapy CDMO Services Basic Information
  10.5.2 Charles River Cell and Gene Therapy CDMO Services Product Overview
  10.5.3 Charles River Cell and Gene Therapy CDMO Services Product Market Performance
  10.5.4 Charles River Business Overview
  10.5.5 Charles River Recent Developments
10.6 OxfordBioMedica
  10.6.1 OxfordBioMedica Cell and Gene Therapy CDMO Services Basic Information
  10.6.2 OxfordBioMedica Cell and Gene Therapy CDMO Services Product Overview
  10.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Product Market Performance
  10.6.4 OxfordBioMedica Business Overview
  10.6.5 OxfordBioMedica Recent Developments
10.7 BrammerBio
  10.7.1 BrammerBio Cell and Gene Therapy CDMO Services Basic Information
  10.7.2 BrammerBio Cell and Gene Therapy CDMO Services Product Overview
  10.7.3 BrammerBio Cell and Gene Therapy CDMO Services Product Market Performance
  10.7.4 BrammerBio Business Overview
  10.7.5 BrammerBio Recent Developments
10.8 CELLfor CURE
  10.8.1 CELLfor CURE Cell and Gene Therapy CDMO Services Basic Information
  10.8.2 CELLfor CURE Cell and Gene Therapy CDMO Services Product Overview
  10.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Product Market Performance
  10.8.4 CELLfor CURE Business Overview
  10.8.5 CELLfor CURE Recent Developments
10.9 OBiO Technology
  10.9.1 OBiO Technology Cell and Gene Therapy CDMO Services Basic Information
  10.9.2 OBiO Technology Cell and Gene Therapy CDMO Services Product Overview
  10.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Product Market Performance
  10.9.4 OBiO Technology Business Overview
  10.9.5 OBiO Technology Recent Developments
10.10 GenScript
  10.10.1 GenScript Cell and Gene Therapy CDMO Services Basic Information
  10.10.2 GenScript Cell and Gene Therapy CDMO Services Product Overview
  10.10.3 GenScript Cell and Gene Therapy CDMO Services Product Market Performance
  10.10.4 GenScript Business Overview
  10.10.5 GenScript Recent Developments
10.11 Esco
  10.11.1 Esco Cell and Gene Therapy CDMO Services Basic Information
  10.11.2 Esco Cell and Gene Therapy CDMO Services Product Overview
  10.11.3 Esco Cell and Gene Therapy CDMO Services Product Market Performance
  10.11.4 Esco Business Overview
  10.11.5 Esco Recent Developments
10.12 Nikon
  10.12.1 Nikon Cell and Gene Therapy CDMO Services Basic Information
  10.12.2 Nikon Cell and Gene Therapy CDMO Services Product Overview
  10.12.3 Nikon Cell and Gene Therapy CDMO Services Product Market Performance
  10.12.4 Nikon Business Overview
  10.12.5 Nikon Recent Developments
10.13 FUJIFILM
  10.13.1 FUJIFILM Cell and Gene Therapy CDMO Services Basic Information
  10.13.2 FUJIFILM Cell and Gene Therapy CDMO Services Product Overview
  10.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Product Market Performance
  10.13.4 FUJIFILM Business Overview
  10.13.5 FUJIFILM Recent Developments
10.14 Pharmaron
  10.14.1 Pharmaron Cell and Gene Therapy CDMO Services Basic Information
  10.14.2 Pharmaron Cell and Gene Therapy CDMO Services Product Overview
  10.14.3 Pharmaron Cell and Gene Therapy CDMO Services Product Market Performance
  10.14.4 Pharmaron Business Overview
  10.14.5 Pharmaron Recent Developments
10.15 Porton
  10.15.1 Porton Cell and Gene Therapy CDMO Services Basic Information
  10.15.2 Porton Cell and Gene Therapy CDMO Services Product Overview
  10.15.3 Porton Cell and Gene Therapy CDMO Services Product Market Performance
  10.15.4 Porton Business Overview
  10.15.5 Porton Recent Developments
10.16 Medicilon
  10.16.1 Medicilon Cell and Gene Therapy CDMO Services Basic Information
  10.16.2 Medicilon Cell and Gene Therapy CDMO Services Product Overview
  10.16.3 Medicilon Cell and Gene Therapy CDMO Services Product Market Performance
  10.16.4 Medicilon Business Overview
  10.16.5 Medicilon Recent Developments
10.17 JOINN Laboratories
  10.17.1 JOINN Laboratories Cell and Gene Therapy CDMO Services Basic Information
  10.17.2 JOINN Laboratories Cell and Gene Therapy CDMO Services Product Overview
  10.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Product Market Performance
  10.17.4 JOINN Laboratories Business Overview
  10.17.5 JOINN Laboratories Recent Developments
10.18 Sofpromed
  10.18.1 Sofpromed Cell and Gene Therapy CDMO Services Basic Information
  10.18.2 Sofpromed Cell and Gene Therapy CDMO Services Product Overview
  10.18.3 Sofpromed Cell and Gene Therapy CDMO Services Product Market Performance
  10.18.4 Sofpromed Business Overview
  10.18.5 Sofpromed Recent Developments
10.19 eXmoor
  10.19.1 eXmoor Cell and Gene Therapy CDMO Services Basic Information
  10.19.2 eXmoor Cell and Gene Therapy CDMO Services Product Overview
  10.19.3 eXmoor Cell and Gene Therapy CDMO Services Product Market Performance
  10.19.4 eXmoor Business Overview
  10.19.5 eXmoor Recent Developments
10.20 OmniaBio
  10.20.1 OmniaBio Cell and Gene Therapy CDMO Services Basic Information
  10.20.2 OmniaBio Cell and Gene Therapy CDMO Services Product Overview
  10.20.3 OmniaBio Cell and Gene Therapy CDMO Services Product Market Performance
  10.20.4 OmniaBio Business Overview
  10.20.5 OmniaBio Recent Developments
10.21 RoslinCT
  10.21.1 RoslinCT Cell and Gene Therapy CDMO Services Basic Information
  10.21.2 RoslinCT Cell and Gene Therapy CDMO Services Product Overview
  10.21.3 RoslinCT Cell and Gene Therapy CDMO Services Product Market Performance
  10.21.4 RoslinCT Business Overview
  10.21.5 RoslinCT Recent Developments
10.22 BioCentriq
  10.22.1 BioCentriq Cell and Gene Therapy CDMO Services Basic Information
  10.22.2 BioCentriq Cell and Gene Therapy CDMO Services Product Overview
  10.22.3 BioCentriq Cell and Gene Therapy CDMO Services Product Market Performance
  10.22.4 BioCentriq Business Overview
  10.22.5 BioCentriq Recent Developments
10.23 PolTREG
  10.23.1 PolTREG Cell and Gene Therapy CDMO Services Basic Information
  10.23.2 PolTREG Cell and Gene Therapy CDMO Services Product Overview
  10.23.3 PolTREG Cell and Gene Therapy CDMO Services Product Market Performance
  10.23.4 PolTREG Business Overview
  10.23.5 PolTREG Recent Developments
10.24 Miltenyi Bioindustry
  10.24.1 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Basic Information
  10.24.2 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Overview
  10.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Market Performance
  10.24.4 Miltenyi Bioindustry Business Overview
  10.24.5 Miltenyi Bioindustry Recent Developments

11 CELL AND GENE THERAPY CDMO SERVICES MARKET FORECAST BY REGION

11.1 Global Cell and Gene Therapy CDMO Services Market Size Forecast
11.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Cell and Gene Therapy CDMO Services Market Size Forecast by Country
  11.2.3 Asia Pacific Cell and Gene Therapy CDMO Services Market Size Forecast by Region
  11.2.4 South America Cell and Gene Therapy CDMO Services Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy CDMO Services by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)

12.1 Global Cell and Gene Therapy CDMO Services Market Forecast by Type (2025-2032)
  12.1.1 Global Forecasted Sales of Cell and Gene Therapy CDMO Services by Type (2025-2032)
  12.1.2 Global Cell and Gene Therapy CDMO Services Market Size Forecast by Type (2025-2032)
  12.1.3 Global Forecasted Price of Cell and Gene Therapy CDMO Services by Type (2025-2032)
12.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Application (2025-2032)
  12.2.1 Global Cell and Gene Therapy CDMO Services Sales (K Units) Forecast by Application
  12.2.2 Global Cell and Gene Therapy CDMO Services Market Size (M USD) Forecast by Application (2025-2032)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy CDMO Services Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell and Gene Therapy CDMO Services Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell and Gene Therapy CDMO Services Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell and Gene Therapy CDMO Services Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2022)
Table 10. Global Market Cell and Gene Therapy CDMO Services Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell and Gene Therapy CDMO Services Sales Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy CDMO Services Product Type
Table 13. Global Cell and Gene Therapy CDMO Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell and Gene Therapy CDMO Services
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy CDMO Services Market Challenges
Table 22. Global Cell and Gene Therapy CDMO Services Sales by Type (K Units)
Table 23. Global Cell and Gene Therapy CDMO Services Market Size by Type (M USD)
Table 24. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Type (2019-2024)
Table 25. Global Cell and Gene Therapy CDMO Services Sales Market Share by Type (2019-2024)
Table 26. Global Cell and Gene Therapy CDMO Services Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell and Gene Therapy CDMO Services Market Size Share by Type (2019-2024)
Table 28. Global Cell and Gene Therapy CDMO Services Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Application
Table 30. Global Cell and Gene Therapy CDMO Services Market Size by Application
Table 31. Global Cell and Gene Therapy CDMO Services Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application (2019-2024)
Table 33. Global Cell and Gene Therapy CDMO Services Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell and Gene Therapy CDMO Services Market Share by Application (2019-2024)
Table 35. Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell and Gene Therapy CDMO Services Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell and Gene Therapy CDMO Services Sales Market Share by Region (2019-2024)
Table 38. North America Cell and Gene Therapy CDMO Services Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell and Gene Therapy CDMO Services Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell and Gene Therapy CDMO Services Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell and Gene Therapy CDMO Services Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell and Gene Therapy CDMO Services Sales by Region (2019-2024) & (K Units)
Table 43. Global Cell and Gene Therapy CDMO Services Production (K Units) by Region (2019-2024)
Table 44. Global Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2019-2024)
Table 46. Global Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Catalent Cell and Gene Therapy CDMO Services Basic Information
Table 52. Catalent Cell and Gene Therapy CDMO Services Product Overview
Table 53. Catalent Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Catalent Business Overview
Table 55. Catalent Cell and Gene Therapy CDMO Services SWOT Analysis
Table 56. Catalent Recent Developments
Table 57. Lonza Cell and Gene Therapy CDMO Services Basic Information
Table 58. Lonza Cell and Gene Therapy CDMO Services Product Overview
Table 59. Lonza Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Lonza Business Overview
Table 61. Lonza Cell and Gene Therapy CDMO Services SWOT Analysis
Table 62. Lonza Recent Developments
Table 63. Thermo Fisher Cell and Gene Therapy CDMO Services Basic Information
Table 64. Thermo Fisher Cell and Gene Therapy CDMO Services Product Overview
Table 65. Thermo Fisher Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Thermo Fisher Cell and Gene Therapy CDMO Services SWOT Analysis
Table 67. Thermo Fisher Business Overview
Table 68. Thermo Fisher Recent Developments
Table 69. WuXi AppTec Cell and Gene Therapy CDMO Services Basic Information
Table 70. WuXi AppTec Cell and Gene Therapy CDMO Services Product Overview
Table 71. WuXi AppTec Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. WuXi AppTec Business Overview
Table 73. WuXi AppTec Recent Developments
Table 74. Charles River Cell and Gene Therapy CDMO Services Basic Information
Table 75. Charles River Cell and Gene Therapy CDMO Services Product Overview
Table 76. Charles River Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Charles River Business Overview
Table 78. Charles River Recent Developments
Table 79. OxfordBioMedica Cell and Gene Therapy CDMO Services Basic Information
Table 80. OxfordBioMedica Cell and Gene Therapy CDMO Services Product Overview
Table 81. OxfordBioMedica Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. OxfordBioMedica Business Overview
Table 83. OxfordBioMedica Recent Developments
Table 84. BrammerBio Cell and Gene Therapy CDMO Services Basic Information
Table 85. BrammerBio Cell and Gene Therapy CDMO Services Product Overview
Table 86. BrammerBio Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. BrammerBio Business Overview
Table 88. BrammerBio Recent Developments
Table 89. CELLfor CURE Cell and Gene Therapy CDMO Services Basic Information
Table 90. CELLfor CURE Cell and Gene Therapy CDMO Services Product Overview
Table 91. CELLfor CURE Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. CELLfor CURE Business Overview
Table 93. CELLfor CURE Recent Developments
Table 94. OBiO Technology Cell and Gene Therapy CDMO Services Basic Information
Table 95. OBiO Technology Cell and Gene Therapy CDMO Services Product Overview
Table 96. OBiO Technology Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. OBiO Technology Business Overview
Table 98. OBiO Technology Recent Developments
Table 99. GenScript Cell and Gene Therapy CDMO Services Basic Information
Table 100. GenScript Cell and Gene Therapy CDMO Services Product Overview
Table 101. GenScript Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. GenScript Business Overview
Table 103. GenScript Recent Developments
Table 104. Esco Cell and Gene Therapy CDMO Services Basic Information
Table 105. Esco Cell and Gene Therapy CDMO Services Product Overview
Table 106. Esco Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Esco Business Overview
Table 108. Esco Recent Developments
Table 109. Nikon Cell and Gene Therapy CDMO Services Basic Information
Table 110. Nikon Cell and Gene Therapy CDMO Services Product Overview
Table 111. Nikon Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Nikon Business Overview
Table 113. Nikon Recent Developments
Table 114. FUJIFILM Cell and Gene Therapy CDMO Services Basic Information
Table 115. FUJIFILM Cell and Gene Therapy CDMO Services Product Overview
Table 116. FUJIFILM Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. FUJIFILM Business Overview
Table 118. FUJIFILM Recent Developments
Table 119. Pharmaron Cell and Gene Therapy CDMO Services Basic Information
Table 120. Pharmaron Cell and Gene Therapy CDMO Services Product Overview
Table 121. Pharmaron Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Pharmaron Business Overview
Table 123. Pharmaron Recent Developments
Table 124. Porton Cell and Gene Therapy CDMO Services Basic Information
Table 125. Porton Cell and Gene Therapy CDMO Services Product Overview
Table 126. Porton Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Porton Business Overview
Table 128. Porton Recent Developments
Table 129. Medicilon Cell and Gene Therapy CDMO Services Basic Information
Table 130. Medicilon Cell and Gene Therapy CDMO Services Product Overview
Table 131. Medicilon Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Medicilon Business Overview
Table 133. Medicilon Recent Developments
Table 134. JOINN Laboratories Cell and Gene Therapy CDMO Services Basic Information
Table 135. JOINN Laboratories Cell and Gene Therapy CDMO Services Product Overview
Table 136. JOINN Laboratories Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. JOINN Laboratories Business Overview
Table 138. JOINN Laboratories Recent Developments
Table 139. Sofpromed Cell and Gene Therapy CDMO Services Basic Information
Table 140. Sofpromed Cell and Gene Therapy CDMO Services Product Overview
Table 141. Sofpromed Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Sofpromed Business Overview
Table 143. Sofpromed Recent Developments
Table 144. eXmoor Cell and Gene Therapy CDMO Services Basic Information
Table 145. eXmoor Cell and Gene Therapy CDMO Services Product Overview
Table 146. eXmoor Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. eXmoor Business Overview
Table 148. eXmoor Recent Developments
Table 149. OmniaBio Cell and Gene Therapy CDMO Services Basic Information
Table 150. OmniaBio Cell and Gene Therapy CDMO Services Product Overview
Table 151. OmniaBio Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. OmniaBio Business Overview
Table 153. OmniaBio Recent Developments
Table 154. RoslinCT Cell and Gene Therapy CDMO Services Basic Information
Table 155. RoslinCT Cell and Gene Therapy CDMO Services Product Overview
Table 156. RoslinCT Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. RoslinCT Business Overview
Table 158. RoslinCT Recent Developments
Table 159. BioCentriq Cell and Gene Therapy CDMO Services Basic Information
Table 160. BioCentriq Cell and Gene Therapy CDMO Services Product Overview
Table 161. BioCentriq Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. BioCentriq Business Overview
Table 163. BioCentriq Recent Developments
Table 164. PolTREG Cell and Gene Therapy CDMO Services Basic Information
Table 165. PolTREG Cell and Gene Therapy CDMO Services Product Overview
Table 166. PolTREG Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. PolTREG Business Overview
Table 168. PolTREG Recent Developments
Table 169. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Basic Information
Table 170. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Overview
Table 171. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. Miltenyi Bioindustry Business Overview
Table 173. Miltenyi Bioindustry Recent Developments
Table 174. Global Cell and Gene Therapy CDMO Services Sales Forecast by Region (2025-2032) & (K Units)
Table 175. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Region (2025-2032) & (M USD)
Table 176. North America Cell and Gene Therapy CDMO Services Sales Forecast by Country (2025-2032) & (K Units)
Table 177. North America Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 178. Europe Cell and Gene Therapy CDMO Services Sales Forecast by Country (2025-2032) & (K Units)
Table 179. Europe Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 180. Asia Pacific Cell and Gene Therapy CDMO Services Sales Forecast by Region (2025-2032) & (K Units)
Table 181. Asia Pacific Cell and Gene Therapy CDMO Services Market Size Forecast by Region (2025-2032) & (M USD)
Table 182. South America Cell and Gene Therapy CDMO Services Sales Forecast by Country (2025-2032) & (K Units)
Table 183. South America Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 184. Middle East and Africa Cell and Gene Therapy CDMO Services Consumption Forecast by Country (2025-2032) & (Units)
Table 185. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 186. Global Cell and Gene Therapy CDMO Services Sales Forecast by Type (2025-2032) & (K Units)
Table 187. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Type (2025-2032) & (M USD)
Table 188. Global Cell and Gene Therapy CDMO Services Price Forecast by Type (2025-2032) & (USD/Unit)
Table 189. Global Cell and Gene Therapy CDMO Services Sales (K Units) Forecast by Application (2025-2032)
Table 190. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Application (2025-2032) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Cell and Gene Therapy CDMO Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy CDMO Services Market Size (M USD), 2019-2032
Figure 5. Global Cell and Gene Therapy CDMO Services Market Size (M USD) (2019-2032)
Figure 6. Global Cell and Gene Therapy CDMO Services Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy CDMO Services Market Size by Country (M USD)
Figure 11. Cell and Gene Therapy CDMO Services Sales Share by Manufacturers in 2023
Figure 12. Global Cell and Gene Therapy CDMO Services Revenue Share by Manufacturers in 2023
Figure 13. Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell and Gene Therapy CDMO Services Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy CDMO Services Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell and Gene Therapy CDMO Services Market Share by Type
Figure 18. Sales Market Share of Cell and Gene Therapy CDMO Services by Type (2019-2024)
Figure 19. Sales Market Share of Cell and Gene Therapy CDMO Services by Type in 2023
Figure 20. Market Size Share of Cell and Gene Therapy CDMO Services by Type (2019-2024)
Figure 21. Market Size Market Share of Cell and Gene Therapy CDMO Services by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell and Gene Therapy CDMO Services Market Share by Application
Figure 24. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application (2019-2024)
Figure 25. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application in 2023
Figure 26. Global Cell and Gene Therapy CDMO Services Market Share by Application (2019-2024)
Figure 27. Global Cell and Gene Therapy CDMO Services Market Share by Application in 2023
Figure 28. Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell and Gene Therapy CDMO Services Sales Market Share by Region (2019-2024)
Figure 30. North America Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2023
Figure 32. U.S. Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell and Gene Therapy CDMO Services Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell and Gene Therapy CDMO Services Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2023
Figure 37. Germany Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell and Gene Therapy CDMO Services Sales Market Share by Region in 2023
Figure 44. China Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 50. South America Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2023
Figure 51. Brazil Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell and Gene Therapy CDMO Services Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell and Gene Therapy CDMO Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell and Gene Therapy CDMO Services Production Market Share by Region (2019-2024)
Figure 62. North America Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2019-2024)
Figure 65. China Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Cell and Gene Therapy CDMO Services Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Cell and Gene Therapy CDMO Services Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Type (2025-2032)
Figure 70. Global Cell and Gene Therapy CDMO Services Sales Forecast by Application (2025-2032)
Figure 71. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Application (2025-2032)